نتائج البحث

Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II HOVON-126/NMSG 21.13 trial

• Authors : Zweegman, Sonja; Stege, Claudia A M; Haukas, Einar

Subjects: Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Boron Compounds; Bortezomib/therapeutic use

• Source: Zweegman , S , Stege , C A M , Haukas , E , Schjesvold , F H , Levin , M-D , Waage , A , Leys , R B L , Klein , S K , Szatkowski , D , Axelsson , P , Hieu Do , T , Knut-Bojanowska , D , van der Spek ,

تفاصيل العنوان